LightGBM-Based Classification of Heart Failure Phenotypes Using Morpho-Energy Features from High-Resolution ECG

Mohamed Amin Gader1,2,3, Sourour Karmani4,5, Ridha Djemal1,2

  • 1Advanced Technologies for Medicine and Signals Laboratory (ATMS), National School of Engineering, University of Sfax, Sfax 3038, Tunisia.

Insights

Artificial intelligence (AI) accurately classifies heart failure (HF) phenotypes using electrocardiogram (ECG) data. This non-invasive AI tool analyzes ECG features to distinguish between HFpEF, HFmrEF, and HFrEF, aiding early diagnosis.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Artificial Intelligence

Background:

  • Heart failure (HF) is a significant global health issue requiring accessible diagnostic methods.
  • Current classification relies on left ventricular ejection fraction (LVEF) assessed via resource-intensive imaging.
  • Electrocardiogram (ECG) offers a low-cost, non-invasive alternative for cardiac assessment.

Purpose of the Study:

  • To develop and validate a multi-algorithm AI framework for automated HF phenotype classification using high-resolution ECG signals.
  • To assess the efficacy of ECG-derived morpho-energy features in discriminating between HFpEF, HFmrEF, and HFrEF phenotypes.
  • To establish AI-driven ECG analysis as a reliable screening tool for HF in resource-limited settings.

Main Methods:

  • A hybrid AI approach combined Pan-Tompkins and NeuroKit2 for ECG signal preprocessing and feature extraction.
  • Extracted temporal, morphological, and energy-based features from segmented ECG beats.
  • Trained and evaluated ensemble machine learning models (LightGBM, XGBoost, etc.) using a 70-15-15 split and 5-fold cross-validation on data from 303 chronic HF patients.

Main Results:

  • The LightGBM model demonstrated superior performance, achieving 98.45% test accuracy, 0.9989 AUC, and 0.9804 macro F1-score.
  • The AI framework effectively outperformed other ensemble models and a stacking classifier.
  • ECG-derived morpho-energy features proved highly effective for HF phenotype discrimination.

Conclusions:

  • AI-driven analysis of ECG morpho-energy features provides a reliable, non-invasive method for early HF phenotype discrimination.
  • This approach can support clinical decision-making and enhance patient management, particularly in resource-limited environments.
  • Automated ECG analysis holds significant potential for improving the accessibility and efficiency of HF diagnosis.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...